drugset / Trial / NCT03401606
Controlled Sedation for Cataract Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
This study evaluates the surgeon and patient´s satisfaction who undergoes cataract surgery using either dexmedetomidine or remifentanil as sedation
Timeline
- Start
- 2014-11-01
- Primary completion
- 2015-10-30
- Completion
- 2016-01-30
Outcome
Outcome not reported
Stopped: “a respiratory depression in remifentanyl group”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 0.125 ug/kg | Intravenous |
| Comparator | Remifentanil | Small molecule | 0.25 ng/ml | Intravenous |
Indications
No indication recorded.